| abstract |
The present invention relates to a ligand-binding molecule which attenuates binding activity to a ligand by being cleaved at a cleavage site, a method for producing the same, a complex formed of the ligand-binding molecule and a ligand, and a ligand comprising the ligand A pharmaceutical composition that binds a fusion protein of a molecule to a ligand, a fusion protein comprising a ligand binding molecule or a ligand binding molecule and a ligand. |